Asia Pacific Enteral Medical Nutrition Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]


No. of Pages: 220    |    Report Code: BMIRE00027515    |    Category: Life Sciences

Asia Pacific Enteral Medical Nutrition Market
Buy Now

The enteral medical nutrition market in Asia Pacific is expected to grow from US$ 1,057.41million in 2022 to US$ 1,641.69 million by 2028. It is estimated to grow at a CAGR of 5.9% from 2022 to 2028. 

Use of Next Generation Technology for Proper Enteral Nutrition Feeding 

In enteral feeding, it is important to calculate patient’s daily and cumulative energy balance, as it helps doctor plan the feeding routing according to the need of patient and decrease the morbidity and mortality risk among the patients. It is also essential to maintain the nutrient supply after discharge. There is no proper technology or equipment available for calculating the patient’s daily and cumulative energy balance. Researchers are now focusing on the use of artificial intelligence (AI) and prediction algorithms for the development of technology that can be used to handle caloric and protein deficit and monitor the energy balance. The next generation technology for enteral nutrition feeding can be used to create communication between ICU and post-ICU discharge units to understand the nutrition regime and predictive deficit. Hospital food left uneaten by patients can be analyzed to evaluate the energy, and protein and vitamins deficits. Similar approach could overcome the deficits in the post ICU period. The implementation of next generation technology-based tools in the critical stage could help to ensure that a patient's nutritional plan and goals are constantly measured, monitored, and achieved. In addition, wearable data could be integrated with Electronic Health Record (EHR) data, including data from sensors continuously measuring physical activity and glucose level. The growing fields of metabolomics and proteomics hold the potential to assess nutritional status, set appropriate adjustments of the nutrient mix, and monitor progress through various stages of illness. Therefore, the use of AI, prediction analytics, metabolomics and proteomics, and many next generation technologies in enteral medical nutrition for proper feeding routine is expected to create lucrative growth opportunities for the enteral medical nutrition market during the forecast period. 

Market Overview 

Asia Pacific is the fastest-growing regional market for enteral medical nutrition and is segmented into China, Japan, India, South Korea, Australia, and the Rest of APAC. The factors contributing to the growth of the enteral nutrition market in these countries are the rising prevalence of chronic diseases and the growing presence of market players across the country, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. 

The countries such as Australia, India, and South Korea are estimated to serve various growth opportunities due to the rising development in the healthcare sector. In addition, the governments of these countries are increasing their efforts for enteral nutrition across the country. Also, the rise in the incidence of chronic diseases and the growing awareness regarding enteral nutrition will likely provide greater growth opportunities to the market players in the coming years. 

Asia Pacific Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million) 

Asia Pacific Enteral Medical Nutrition Market Revenue and Forecast to 2028 (US$ Million) 
Get more information on this report

Asia Pacific Enteral Medical Nutrition Strategic Insights

Strategic insights for the Asia Pacific Enteral Medical Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/asia-pacific-enteral-medical-nutrition-market-strategic-framework.webp
Get more information on this report

Asia Pacific Enteral Medical Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 1,057.41 Million
Market Size by 2028 US$ 1,641.69 Million
Global CAGR (2022 - 2028) 5.9%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Indication
  • Respiratory Disorders
  • Cancer
  • Post COVID-19
  • Gastrointestinal Disorders
  • Liver Failure
By Nutrition Type
  • Supplemental and Sole-Source
By Form
  • Powder
  • Liquid
  • Semi-Solid
By Product
  • Standard Protein Diet
  • High Protein Diet
  • Fruit Juice Based Oral Nutritional Supplement
By Distribution Channel
  • Hospital Pharmacies
  • Retail Stores
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DSM Nutritional Products AG
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestlé S.A.
  • Nutricia
  • Smartfish AS
  • Get more information on this report

    Asia Pacific Enteral Medical Nutrition Regional Insights

    The geographic scope of the Asia Pacific Enteral Medical Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/asia-pacific-enteral-medical-nutrition-market-geography.webp
    Get more information on this report

    Asia Pacific Enteral Medical Nutrition Market Segmentation 

    The Asia Pacific enteral medical nutrition market is segmented into indication, nutrition type, form, product, distribution channel, age group and country. 

    Based on indication, the Asia Pacific enteral medical nutrition market is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, and others. The respiratory disorders segment held the largest share in 2022. Based on nutrition type, the Asia Pacific enteral medical nutrition market is segmented into supplemental and sole source. The supplemental segment held the largest share of the market in 2022. Based on form, the Asia Pacific enteral medical nutrition market is segmented into powder, liquid, and semi-solid. The semi-solid segment held the largest share of the market in 2022. Based on product, the Asia Pacific enteral medical nutrition market is segmented into standard protein diet, high protein diet, fruit juice based oral nutrition, and others. The standard protein diet segment held the largest share of the market in 2022. Based on distribution channel, the Asia Pacific Enteral Medical Nutrition market is segmented into Hospital Pharmacies, Retail Stores and Other Pharmacies. The Hospital pharmacies segment held the largest share of the market in 2022. Based on Age Group, the Asia Pacific enteral medical nutrition market is segmented into child (till 18 years) and adults (above 18 years). The adult segment held the largest share of the market in 2022. Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market in 2022. Abbott Laboratories; B. Braun Melsungen AG; DSM Nutritional Products AG; Fresenius Kabi AG; Global Health Products, Inc.; Hormel Foods Corporation; Meiji Holdings Co., Ltd.; Nestlé S.A.; Nutricia; and Smartfish AS are the leading companies operating in the enteral medical nutrition market in the region.

    The List of Companies - Asia Pacific Enteral Medical Nutrition Market

    1. Abbott Laboratories
    2. B. Braun Melsungen AG
    3. DSM Nutritional Products AG
    4. Fresenius Kabi AG
    5. Global Health Products, Inc.
    6. Hormel Foods Corporation
    7. Meiji Holdings Co., Ltd.
    8. Nestlé S.A.
    9. Nutricia
    10. Smartfish AS
    Frequently Asked Questions
    How big is the Asia Pacific Enteral Medical Nutrition Market?

    The Asia Pacific Enteral Medical Nutrition Market is valued at US$ 1,057.41 Million in 2022, it is projected to reach US$ 1,641.69 Million by 2028.

    What is the CAGR for Asia Pacific Enteral Medical Nutrition Market by (2022 - 2028)?

    As per our report Asia Pacific Enteral Medical Nutrition Market, the market size is valued at US$ 1,057.41 Million in 2022, projecting it to reach US$ 1,641.69 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Enteral Medical Nutrition Market report typically cover these key segments-

    • Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure)
    • Nutrition Type (Supplemental and Sole-Source)
    • Form (Powder, Liquid, Semi-Solid)
    • Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement)
    • Distribution Channel (Hospital Pharmacies, Retail Stores)

    What is the historic period, base year, and forecast period taken for Asia Pacific Enteral Medical Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Enteral Medical Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Asia Pacific Enteral Medical Nutrition Market?

    The Asia Pacific Enteral Medical Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • DSM Nutritional Products AG
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Meiji Holdings Co., Ltd.
  • Nestlé S.A.
  • Nutricia
  • Smartfish AS
  • Who should buy this report?

    The Asia Pacific Enteral Medical Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Enteral Medical Nutrition Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now